Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

BACKGROUND: In luminal androgen receptor (AR) tumours, FOXA1 may direct AR to sites occupied by ER in luminal tumours, thus stimulating proliferation. METHODS: AR and FOXA1 expression were evaluated by immunohistochemistry in 333 non-metastatic triple-negative breast cancers (TNBC). Positivity thres...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiu, Séverine, Mollevi, Caroline, Charon-Barra, Céline, Boissière, Florence, Crapez, Evelyne, Chartron, Elodie, Lamy, Pierre-Jean, Gutowski, Marian, Bourgier, Céline, Romieu, Gilles, Simony-Lafontaine, Joelle, Jacot, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035246/
https://www.ncbi.nlm.nih.gov/pubmed/29880907
http://dx.doi.org/10.1038/s41416-018-0142-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035246/
https://www.ncbi.nlm.nih.gov/pubmed/29880907
http://dx.doi.org/10.1038/s41416-018-0142-6

Ejemplares similares